Practice
Navara Health, PLLC
5301 Alpha Road, Suite 34, Room 21
Dallas, Texas 75240
Contact
469-653-3124
contact@navarahealthtx.com
Treating Provider / Delegating APRN
Jessica Boggs, MSN, APRN, FNP-C, ENP-C
Aesthetic RN Injector
Rocio Gonzalez, RN
Injects under APRN delegation & GFE oversight
Medical Director
Simal Patel, MD
Texas BON / TMB Compliance
Good Faith Exam completed prior to injection
Written delegation & standing orders on file
Service Location
Dallas, Texas (In-Clinic Only · Adults 18+)
Purpose of This Consent
This is a procedure-specific informed consent for injectable neurotoxin and dermal filler treatments. It is in addition to, and where it conflicts, controls over, the Navara Health General Aesthetic Informed Consent.
Two product categories are covered by this consent: (1) Neurotoxins — botulinum toxin products that relax muscle activity, and (2) Dermal Fillers — hyaluronic acid (HA) and other injectable products that restore volume and contour. The risk profiles of these two product categories are different and are addressed separately below.
Authorization for Treatment & Provider Identification
I authorize the following clinicians at Navara Health, PLLC to evaluate me and perform neurotoxin and/or dermal filler injections as clinically appropriate:
- Jessica Boggs, MSN, APRN, FNP-C, ENP-C — delegating Advanced Practice Registered Nurse, treating provider, and clinical oversight
- Rocio Gonzalez, RN — Registered Nurse injector, performing injections under written APRN delegation, Good Faith Exam oversight, and medical director protocols, consistent with Texas Board of Nursing and Texas Medical Board rules
I understand and agree that:
- A Good Faith Exam (GFE) by the delegating APRN (in person or via permitted telehealth where appropriate) will be completed prior to my first injectable treatment and as clinically indicated for subsequent visits
- The GFE assesses my candidacy, medical history, contraindications, and treatment plan
- Injections may be performed by either Jessica Boggs APRN or Rocio Gonzalez, RN under appropriate delegation and oversight
- I may request to be seen by a specific provider; that request will be accommodated when possible
- Either clinician may decline to perform a requested treatment if it is clinically inappropriate or unsafe
Products & Treatment Description
Category A · Neurotoxins
Botulinum Toxin Type A
FDA-approved products that temporarily relax targeted muscles to soften dynamic wrinkles and prevent new lines. Common uses: glabellar lines ("11s"), forehead lines, crow's feet, bunny lines, lip flip, masseter (jaw slimming and bruxism), platysmal bands, neck lift, hyperhidrosis, gummy smile, chin dimpling.
Category B · Dermal Fillers
Injectable Soft Tissue Fillers
FDA-approved hyaluronic acid (HA) fillers and other biostimulators used to restore volume, contour facial features, and improve fine lines, folds, and asymmetries. Common areas: lips, cheeks, midface, jawline, chin, tear troughs, nasolabial folds, marionette lines, perioral lines, hands.
Products Used at Navara Health
| Product | Type | Common Uses |
| Botox® / Botox® Cosmetic | Neurotoxin (onabotulinumtoxinA) | Dynamic lines, hyperhidrosis |
| Dysport® | Neurotoxin (abobotulinumtoxinA) | Dynamic lines, faster onset |
| Xeomin® | Neurotoxin (incobotulinumtoxinA) | Dynamic lines, "naked" formulation |
| Jeuveau® | Neurotoxin (prabotulinumtoxinA) | Dynamic lines |
| Letybo® | Neurotoxin (letibotulinumtoxinA) | Glabellar lines |
| Daxxify® | Neurotoxin (daxibotulinumtoxinA) | Dynamic lines, longer duration |
| Juvéderm® family | HA filler | Lips, cheeks, folds, midface, jaw |
| Restylane® family | HA filler | Lips, tear troughs, midface, hands |
| RHA® collection | HA filler (resilient) | Dynamic areas, perioral |
| Belotero® | HA filler (fine lines) | Perioral, superficial lines |
I understand that the specific product, dose (units for neurotoxin or mL for filler), and injection sites will be selected by my injector based on my anatomy, goals, and clinical judgment, and will be discussed with me prior to injection.
Expected Results & Onset / Duration
Neurotoxins
- Onset typically begins 3–7 days post-injection
- Peak effect occurs at approximately 10–14 days
- Duration of effect varies by product, dose, metabolism, and treatment area
Typical Duration by Product
- Botox®, Dysport®, Jeuveau®, Xeomin®, Letybo®: approximately 3–4 months (90–120 days)
- Daxxify®: may last longer (up to approximately 6 months) in some patients, though duration varies and is not guaranteed
FDA Approval & On-Label vs. Off-Label Use
- Botulinum toxin products are FDA-approved for specific cosmetic indications that vary by product, commonly including glabellar lines ("11s"), crow's feet, and forehead lines
- Injection into other areas — including masseters, neck (platysmal) bands, chin, lip flip, brow lift, gummy smile, underarms, or other medical or aesthetic indications — is considered off-label for some products
- Off-label use is legal, common, and accepted in aesthetic medicine, and is at the provider's clinical discretion
- No guarantees are made regarding cosmetic outcome, symmetry, or longevity
Treatment Continuity
- Repeated treatments are required to maintain results
- Initial treatments may have shorter duration; results may extend with consistent treatment
- Long-term improvement in dynamic wrinkles may occur with consistent use, but no permanent effect is guaranteed
Dermal Fillers
- Volume effect is immediate; final result settles over 2–4 weeks as swelling resolves and product integrates
- Typical duration ranges from 6 months to 2+ years depending on product, area, metabolism, and lifestyle
- HA filler can be partially or fully dissolved with hyaluronidase if needed for adjustment or complication
- Some products are biostimulatory (not pure HA) and cannot be dissolved with hyaluronidase
Results are not guaranteed. Individual response, anatomy, metabolism, and lifestyle (sun, smoking, exercise intensity, hormonal factors) affect both visible result and longevity.
Risks & Possible Complications — Neurotoxins
Common / Expected
Injection-Site Effects
Mild pain or pinch at injection. Pinpoint bleeding. Bruising. Redness or small bumps at injection sites resolving within minutes to hours. Mild headache (especially first treatment). Tightness or "heavy" sensation.
Less Common
Functional & Cosmetic
Eyelid ptosis (drooping eyelid) typically 1–4 weeks duration.
Brow ptosis or asymmetric brow position ("Spock brow"). Asymmetric smile or mouth movement. Dry eye, watery eye, or blurred vision. Difficulty making certain expressions. Flu-like symptoms or mild nausea. Allergic or sensitivity reaction. Antibody formation reducing future response.
Rare but Serious
Significant Risks
Anaphylaxis or severe allergic reaction.
Distant spread of toxin effect (see emergency callout below). Worsening of underlying neuromuscular disease (myasthenia gravis, Lambert-Eaton, ALS). Cardiovascular events (very rare).
FDA Boxed Warning · Distant Spread of Toxin Effect
All botulinum toxin products — including Botox®, Dysport®, Jeuveau®, Xeomin®, Letybo®, and Daxxify® — carry a risk of spread of toxin effect beyond the injection site. Symptoms may occur hours, days, or weeks after injection and may include:
- Hoarseness or voice changes
- Slurred speech
- Difficulty swallowing (dysphagia)
- Difficulty breathing
- Generalized muscle weakness
- Loss of bladder control
- Drooping eyelids or double vision
Swallowing or breathing difficulties may be life-threatening and require emergency medical care. If these symptoms occur, call 911 immediately, then notify Navara Health.
Risks & Possible Complications — Dermal Fillers
Common / Expected
Injection-Site Effects
Swelling, redness, bruising, tenderness, or itching at injection sites — typically resolves within days to 2 weeks. Lumps or palpable product that softens as it integrates. Asymmetry that often resolves with swelling. Discomfort with chewing or facial expressions.
Less Common
Product-Related Complications
Persistent nodules or palpable lumps. Migration of product to unintended areas. Tyndall effect (bluish discoloration in thin skin, especially tear troughs). Prolonged swelling or erythema.
Delayed inflammatory or immune reactions (sometimes weeks to months later, including after illness, vaccination, or dental work). Hypersensitivity reaction. Granuloma formation. Infection. Reactivation of cold sores (herpes simplex) — prophylactic antiviral may be advised for patients with a history.
Rare but Serious
Vascular Complications
Vascular occlusion (blood vessel blockage), tissue ischemia, skin necrosis, scarring. Blindness or permanent visual disturbance from accidental intra-arterial injection — documented in the medical literature, most commonly with injections near the glabella, nose, forehead, nasolabial folds, and tear troughs. Stroke or cerebrovascular event. Severe allergic reaction or anaphylaxis. Hematoma. Ulceration or tissue erosion. Nerve injury or prolonged numbness. Long-term cosmetic distortion requiring corrective procedures.
Vascular Occlusion is a Medical Emergency
Vascular occlusion can occur even with proper technique. Emergency corrective interventions — including hyaluronidase administration, warm compresses, massage, nitroglycerin paste, aspirin, antibiotics, and/or referral for emergency or specialty care — may be required.
These interventions may involve additional cost that is my financial responsibility. Hyaluronidase reversal carries its own risks (allergic reaction, dissolution of desired filler) and is only effective for HA-based fillers.
Contraindications & Precautions
I should not receive neurotoxin or filler treatment, or treatment may be delayed/modified, if I have or disclose:
- Pregnancy, possible pregnancy, or breastfeeding
- Active skin infection, acne flare, cold sore, or open wound at or near the injection site
- Active sinus infection (caution with midface/cheek filler)
- Known allergy or hypersensitivity to the proposed product or its components (including lidocaine in pre-mixed fillers)
- History of severe allergic reaction to any aesthetic injectable
- Neuromuscular disorders (myasthenia gravis, Lambert-Eaton syndrome, ALS) — neurotoxin contraindicated
- Significant swallowing or breathing disorders — neurotoxin contraindicated
- Receiving botulinum toxin injections elsewhere in my body (medical or cosmetic) without full disclosure to Navara Health
- Bleeding disorders or current anticoagulant therapy (increased bruising risk)
- Recent or upcoming dental procedures (caution within 2 weeks before/after filler)
- Recent or upcoming vaccinations (caution within 2 weeks before/after filler)
- Autoimmune disease (caution; case-by-case review)
- History of keloids or hypertrophic scarring
- Significant facial asymmetry or congenital ptosis
- Unrealistic expectations
- Body dysmorphic concerns
Pre- and Post-Procedure Responsibilities
Before Treatment
- Disclose all medications, supplements, blood thinners, recent procedures, and vaccinations
- Avoid NSAIDs, fish oil, vitamin E, ginkgo, garlic supplements, and alcohol for 48–72 hours before (unless medically required)
- Notify injector of cold sore history (prophylactic antiviral may be recommended)
- Avoid waxing, dermaplaning, peels, or lasers in the treatment area for at least 1 week before
- Arrive with clean skin, free of makeup if requested
After Neurotoxin
- Remain upright for at least 4 hours
- Avoid rubbing, massaging, or applying pressure to treated areas for 24 hours
- Avoid strenuous exercise, saunas, hot tubs, and significant heat exposure for 24 hours
- Avoid lying face-down or on the treated area for 24 hours
- Avoid additional facial treatments (peels, lasers, massage) for at least 2 weeks
- Expect onset over 3–14 days; do not request "more" before the 14-day mark
After Dermal Filler
- Avoid touching, rubbing, or pressing on treated areas for 24–48 hours
- Apply cold compresses gently to reduce swelling
- Avoid strenuous exercise, alcohol, saunas, and hot tubs for 24–48 hours
- Avoid dental procedures and facial treatments for at least 2 weeks
- Sleep with head elevated for 1–2 nights
- Final result may take 2–4 weeks; do not request touch-up before then
- Maintain proper sun protection (SPF 30+) during recovery
Call Navara Health Immediately for
- Skin blanching, white, dusky, or mottled color in or around an injection site
- Severe or worsening pain hours to days after the procedure
- Any visual change, eye pain, or new headache after facial injection
- Difficulty swallowing, breathing, or speaking (after neurotoxin)
- Significant or sudden generalized muscle weakness
- Spreading redness, fever, drainage, or signs of infection
- Severe allergic reaction (hives, facial swelling, anaphylaxis)
For life-threatening symptoms (vision loss, stroke symptoms, anaphylaxis), call 911 first, then notify Navara Health.
Off-Label Use Disclosure
Some neurotoxin and filler uses are off-label, meaning they have not received specific FDA approval for that indication, even though the product is FDA-approved for other uses. Off-label use is legal, common, and accepted in aesthetic medicine and is at the provider's clinical discretion. Examples include:
- Neurotoxin for masseter slimming, lip flip, neck (Nefertiti) lift, gummy smile, chin dimpling, platysmal bands, hyperhidrosis sites beyond the underarms
- Filler use in lips, chin, jawline, tear troughs, hands, earlobes, or other off-label sites depending on the specific product's labeling
Financial Disclosure
I understand and agree that:
- Neurotoxin and filler treatments are elective and not covered by insurance
- Navara Health is a cash-pay practice and does not bill, verify, or submit claims to insurance, Medicare, or Medicaid for aesthetic services
- Payment is due at the time of service
- No refunds are issued once a syringe has been opened or any product has been injected
- If a touch-up is needed within the provider's standard touch-up window, additional cost may apply
- Treatment of complications, including hyaluronidase reversal, prescription medications, antibiotics, or specialty referral, may incur additional cost that is my financial responsibility
- Pre-paid packages and memberships are non-refundable except as expressly stated in writing
Communication & HIPAA Authorization
I authorize Navara Health to communicate with me regarding scheduling, pre/post-procedure instructions, follow-up, and adverse event reporting through:
- The secure HIPAA-compliant patient portal
- Email to the address I have provided
- SMS / text message to the mobile number I have provided
- Telephone calls to the number I have provided
I understand that email and SMS are not fully secure channels. I may revoke authorization for any specific channel in writing to contact@navarahealthtx.com, except where required for legally mandated notices.
Assumption of Risk & Release of Liability
I voluntarily assume all known and unknown risks associated with neurotoxin and dermal filler treatment. To the fullest extent permitted by law, I agree to release, indemnify, and hold harmless Navara Health, PLLC, Jessica Boggs APRN, Rocio Gonzalez RN, the medical director, and all affiliated providers, nurses, contractors, and staff from liability related to:
- Adverse reactions or complications
- Side effects, asymmetry, or atypical product response
- Cosmetic dissatisfaction with the result
- Need for additional, corrective, dissolution, or maintenance procedures
- Conditions not disclosed prior to treatment
This release does not apply to cases of gross negligence or willful misconduct, and does not waive any right that cannot lawfully be waived under the laws of the State of Texas.
Dispute Resolution & Binding Arbitration
Any dispute, controversy, or claim arising out of or relating to this Consent, the procedure performed, or the practitioner-patient relationship — including any claim of medical malpractice, billing dispute, or breach of contract — shall first be addressed by good-faith negotiation between the parties.
If the matter cannot be resolved through negotiation within thirty (30) days, the parties agree to submit the dispute to binding arbitration administered by a recognized arbitration body (such as the American Arbitration Association) under its applicable rules, with the arbitration to take place in Dallas County, Texas.
The parties acknowledge that by agreeing to arbitration, they are waiving the right to a jury trial. This provision does not waive any right that cannot lawfully be waived under Texas law. Either party retains the right to seek injunctive or equitable relief in court where appropriate.
Governing Law & Severability
This Consent shall be governed by and construed under the laws of the State of Texas. If any provision is found unenforceable, the remaining provisions shall remain in full force and effect.
Photography & Marketing Authorization
Photographs taken before, during, and after injectable treatments serve different purposes, and I am being asked to provide separate consent for each use. I understand I may consent to medical documentation while declining marketing use, or vice versa.
Photography Use — Please Initial Each Option
Required · Medical Documentation
I consent to clinical photographs of the treatment area being taken before, during, and after services for the purpose of medical documentation, treatment planning, and inclusion in my confidential medical record. These photographs will not be shared outside the practice without further written authorization.
Optional · Marketing & Promotional Use
I additionally authorize Navara Health, PLLC to use my before/after photographs in marketing materials, including the practice website, social media (Instagram, Facebook, TikTok, etc.), printed materials, advertisements, and educational content. My face may be identifiable in these images. No compensation will be provided. I may revoke this authorization at any time in writing, and Navara Health will stop using the images going forward, though I understand previously published images cannot always be recalled from third parties or the internet.
Optional · De-Identified Marketing Use Only
I authorize use of my before/after photographs in marketing materials only with my face de-identified (eyes/identifying features cropped or obscured). I do not authorize identifiable images for marketing.
Optional · Provider Education & Conferences
I authorize use of my before/after photographs (identifiable or de-identified, as initialed above) in professional education contexts, including conferences, clinician training, peer education, and published case reports.
Patient Signature (Photography & Marketing)
Patient Initials — Required for Each Critical Clause
Each of the following clauses requires my separate written initials. By initialing, I confirm that I understand and agree to each individual clause.
I understand that injection may be performed by Rocio Gonzalez, RN under APRN delegation, and that a Good Faith Exam by Jessica Boggs, APRN has been or will be completed.
I understand the specific risks of vascular occlusion, tissue ischemia, scarring, and rare but documented vision loss with dermal filler, and I accept these risks.
I understand the FDA boxed warning regarding distant spread of neurotoxin effect and the risk of generalized muscle weakness, swallowing, or breathing difficulty (extremely rare).
I understand that emergency corrective treatments (including hyaluronidase) may be required at additional cost if a filler complication occurs.
I understand that no refunds are issued once a syringe is opened or any product is injected.
I will wait at least 14 days after neurotoxin and 2–4 weeks after filler before requesting touch-ups or assessing final results.
I agree to binding arbitration as described in Section 12 and understand that I am waiving the right to a jury trial.
Patient Acknowledgment & Electronic Consent
By signing below (or by typing my full legal name as an electronic signature), I acknowledge and affirm:
- I am at least 18 years of age or legally authorized to consent.
- I have read this Neurotoxin & Dermal Filler Informed Consent in its entirety.
- I fully understand the procedure, risks, benefits, limitations, and alternatives.
- I understand that injection may be performed by either Jessica Boggs, APRN or Rocio Gonzalez, RN under APRN delegation, with a Good Faith Exam completed by the delegating APRN.
- I have had the opportunity to ask questions, and all questions have been answered to my satisfaction.
- I have disclosed my complete medical history, allergies, medications, supplements, vaccinations, and recent procedures.
- I understand the differences in risk profile between neurotoxin and dermal filler treatments.
- I understand that hyaluronidase reversal may be needed for HA filler complications and is associated with additional cost and risk.
- I accept full financial responsibility and understand that no refunds are issued once a syringe is opened or product is injected.
- I authorize communication through the channels described in Section 10.
- I voluntarily assume all known and unknown risks and agree to the release of liability described in Section 11.
- I agree to binding arbitration as described in Section 12 and understand that I am waiving the right to a jury trial.
- I have completed the separate Photography & Marketing Authorization and initialed each critical clause above.
- I voluntarily consent to neurotoxin and/or dermal filler treatment at Navara Health, PLLC.
- My typed name serves as my legal electronic signature, equivalent to a handwritten signature, and this consent becomes part of my permanent medical record.
Treatment Type (Neurotoxin / Filler / Both)
Patient Signature (or Typed Electronic Signature)
Injector Signature (Jessica Boggs, APRN or Rocio Gonzalez, RN)
Delegating APRN Signature (Jessica Boggs, APRN) — GFE Completed